Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Accenture
Cerilliant
McKinsey
Covington
UBS
Chinese Patent Office
Baxter
Argus Health
AstraZeneca

Generated: February 20, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,081,154

« Back to Dashboard

Summary for Patent: 5,081,154
Title: Metoprolol succinate
Abstract:The present invention relates to metoprolol succinate, a new therapeutically active compound, and pharmaceutical preparations comprising this new compound.
Inventor(s): Appelgren; Curt H. (Kungsbacka, SE), Eskilsson; Eva C. (Molnlycke, SE)
Assignee: Aktiebolaget Hassle (Molndal, SE)
Application Number:07/590,237
Patent Claim Types:
see list of patent claims
Compound;

Drugs Protected by US Patent 5,081,154

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,081,154

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Sweden8400085Jan 10, 1984

International Patents Family Members for US Patent 5,081,154

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 46080 ➤ Try a Free Trial
Austria 77077 ➤ Try a Free Trial
Germany 3572767 ➤ Try a Free Trial
Germany 3586206 ➤ Try a Free Trial
European Patent Office 0148811 ➤ Try a Free Trial
European Patent Office 0293347 ➤ Try a Free Trial
Hong Kong 24995 ➤ Try a Free Trial
Latvia 5814 ➤ Try a Free Trial
Sweden 457505 ➤ Try a Free Trial
Sweden 462529 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Express Scripts
Colorcon
Medtronic
Queensland Health
Harvard Business School
Boehringer Ingelheim
Citi
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot